Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

BorgWarner (BWA) Q1 Earnings Beat Estimates, Gains Y/Y

Published 04/26/2018, 08:49 AM
Updated 07/09/2023, 06:31 AM

BorgWarner Inc. (NYSE:BWA) offers efficient and clean technology solutions, essential for combustion, hybrid and electric vehicles. The company reported adjusted earnings of $1.10 per share in first-quarter 2018, beating the Zacks Consensus Estimate of $1.03. Adjusted earnings increased from 91 cents reported in the year-ago quarter.

Revenues

BorgWarner logged revenues of $2.78 billion, beating the Zacks Consensus Estimate of $2.63 billion. The revenue figure for first-quarter 2017 was $2.41 billion.

Estimate Trend & Surprise History

Investors should note that stock has witnessed an upward trend in the Zacks Consensus Estimate for annual earnings over the last seven days.

The company delivered positive earnings surprises in the trailing four quarters, leading to an average beat of around 7.6%.

BorgWarner Inc. Price and EPS Surprise

Zacks Rank

BorgWarner currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

We have highlighted some of the key stats from this Michigan-based company’s earnings announcement below:

Key Stats/Developments to Note

For second-quarter 2018, the company envisions net earnings to lie within the range of $1.09 to $1.11 per share. Moreover, it expects net organic sales growth of 7-9% compared with net sales of $2.39 billion in the year-ago quarter. The acquisition of Sevcon will contribute $50 million in net sales.

For full-year 2018, the company reaffirmed organic growth guidance. It projects net sales of around $10.77-$10.94 billion, which translates into an organic growth rate of 5-7%. Further, the company expects net earnings within the range of $4.30-$4.40.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Furthermore, BorgWarner expects the positive impact of foreign currencies on the appreciation of the Euro and Chinese Yuan of $405 million.

Check back later for our full write up on BorgWarner’s earnings report!

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>



BorgWarner Inc. (BWA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.